Kane Shubhada, Khurana Aditi, Parulkar Gorakh, Shet Tanuja, Prabhash Kumar, Nair Reena, Gujral Sumeet
Department of Pathology, Tata Memorial Hospital, Mumbai, India.
J Oral Pathol Med. 2009 Jan;38(1):138-44. doi: 10.1111/j.1600-0714.2008.00673.x. Epub 2008 Jul 21.
Haematolymphoid tumours other than plasmablastic lymphoma (PBL) may reveal plasmablastic differentiation with overlapping immunoreactivity causing diagnostic dilemma. Elaborate ancillary diagnostic techniques can make the process expensive, tedious and out of reach for pathology laboratory in a developing country.
Out of 98 total cases of primary non-Hodgkin's lymphoma and plasmacytoma of oral-sinonasal region recorded in our institute over 4 years, 39 cases showing varied plasmablastic differentiation were selected. Morphological and immunohistochemical criteria were applied to identify minimum diagnostic criteria for PBL. Human Immunodeficiency Virus (HIV) correlation and Epstein-Barr virus expressed RNA (EBER) in-situ hybridisation studies were also performed.
Minimum morphological criteria required to diagnose PBL were: (1) predominant population of plasmablasts which are large monomorphic cells with high nuclear-cytoplasmic ratio, moderate amount of amphophilic cytoplasm and round nucleus with prominent central nucleolus, (2) high mitotic and/or apoptotic index and (3) absence of neoplastic plasma cells in the background. Essential diagnostic immunophenotype consisted of CD20 negativity, LCA +/-, CD138/VS38c diffuse positivity, light chain restriction and high MIB-1 index (>60 %). Twenty-five of the total 32 PBL cases thus identified, involved oral cavity. Of these, 84% affected gingivo-buccal complex. Twenty-eight cases were HIV positive. EBER positivity confirmed the diagnosis in all the HIV-negative cases.
A triad of 'rapidly growing lesion with predilection for oral mucosa, classical plasmablastic morphology and limited immunohistochemical panel' can render a reliable diagnosis of PBL, irrespective of HIV and EBV status, especially in developing countries with limited resources.
除浆母细胞淋巴瘤(PBL)外的血液淋巴肿瘤可能表现出浆母细胞分化,伴有重叠的免疫反应性,从而导致诊断困境。复杂的辅助诊断技术可能会使过程昂贵、繁琐,且发展中国家的病理实验室难以企及。
在我们研究所4年记录的98例口腔鼻窦区原发性非霍奇金淋巴瘤和浆细胞瘤病例中,选择了39例表现出不同程度浆母细胞分化的病例。应用形态学和免疫组织化学标准来确定PBL的最低诊断标准。还进行了人类免疫缺陷病毒(HIV)相关性和爱泼斯坦-巴尔病毒编码RNA(EBER)原位杂交研究。
诊断PBL所需的最低形态学标准为:(1)以浆母细胞为主,浆母细胞为大的单形性细胞,核质比高,有中等量的嗜双色性细胞质,核圆形,中央核仁突出;(2)有高的有丝分裂和/或凋亡指数;(3)背景中无肿瘤性浆细胞。必要的诊断免疫表型包括CD20阴性、LCA +/-、CD138/VS38c弥漫阳性、轻链限制和高MIB-1指数(>60%)。在总共32例确诊的PBL病例中,25例累及口腔。其中,84%累及牙龈颊复合体。28例HIV阳性。EBER阳性在所有HIV阴性病例中均证实了诊断。
“好发于口腔黏膜的快速生长病变、典型的浆母细胞形态和有限的免疫组织化学检测项目”这三者结合,无论HIV和EBV状态如何,均可对PBL做出可靠诊断,尤其是在资源有限的发展中国家。